Tsoukas, M. A. (2023). Glucagon-like Peptide-1 Receptor Agonist Treatment in Type 1 Diabetes: A Review of Current Evidence and Rationale for Use. Canadian Diabetes & Endocrinology Today, 1(3), 21–26. https://doi.org/10.58931/cdet.2023.1318